New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
07:59 EDTZGNX, ESRXZogenix price target lowered to $2.50 from $5 at Oppenheimer
Oppenheimer cut its price target on Zogenix (ZGNX) after coverage of the company's Zohydro painkiller was terminated by Express Scripts (ESRX). However, the firm thinks recent disappointing news about Zogenix is already reflected in the stock. Oppenheimer keeps an Outperform rating on the shares.
News For ZGNX;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
16:37 EDTESRXSpecialists On Call names Hammad Shah as CEO
Subscribe for More Information
11:45 EDTESRXLeerink healthcare tech/pharma analysts hold analyst/industry conference call
Subscribe for More Information
March 18, 2015
11:07 EDTZGNXBroadfin Capital reports 7.0% passive stake in Zogenix
Subscribe for More Information
March 17, 2015
08:04 EDTESRXExpress Scripts has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO George Paz on March 18 at 11 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use